Compare UNF & BLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | UNF | BLCO |
|---|---|---|
| Founded | 1936 | 1853 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Business Services | Ophthalmic Goods |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.3B | 5.4B |
| IPO Year | 1994 | 2022 |
| Metric | UNF | BLCO |
|---|---|---|
| Price | $292.00 | $16.65 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 3 | 11 |
| Target Price | ★ $238.33 | $18.45 |
| AVG Volume (30 Days) | 140.7K | ★ 415.6K |
| Earning Date | 04-01-2026 | 04-29-2026 |
| Dividend Yield | ★ 0.57% | N/A |
| EPS Growth | ★ 2.70 | N/A |
| EPS | ★ 4.11 | N/A |
| Revenue | $1,696,489,000.00 | ★ $5,101,000,000.00 |
| Revenue This Year | $3.69 | $8.65 |
| Revenue Next Year | $3.53 | $5.59 |
| P/E Ratio | $70.91 | ★ N/A |
| Revenue Growth | ★ 6.63 | 6.47 |
| 52 Week Low | $147.66 | $13.53 |
| 52 Week High | $306.67 | $18.92 |
| Indicator | UNF | BLCO |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 54.41 |
| Support Level | N/A | $16.07 |
| Resistance Level | N/A | $16.73 |
| Average True Range (ATR) | 0.00 | 0.53 |
| MACD | 0.00 | 0.03 |
| Stochastic Oscillator | 0.00 | 66.55 |
UniFirst Corp provides uniform and workwear programs, facility management, and safety supplies and services across North America. It designs, manufactures, rents, cleans, and sells uniforms and protective clothing, including flame-resistant and high-visibility garments. It also offers industrial wiping products, floor mats, cleaning supplies, first aid cabinets, and fire protection services such as inspection and maintenance. Serving various industries, the company provides customized uniforms and specialized cleaning for nuclear and cleanroom facilities. It operates through three segments: Uniform & Facility Service Solutions, First Aid & Safety Solutions, and Other, with the majority of revenue from Uniform & Facility Service Solutions.
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.